The global red biotechnology market is projected to grow from $381.01 billion in 2023 to $699.31 billion by 2033, driven by rising chronic disease prevalence and increased healthcare funding. Key players like Pfizer and Amgen are advancing drug development, particularly in precision medicine, despite high trial failure rates. Recent mergers, such as Ipsen's acquisition of Albireo, highlight ongoing consolidation in the sector.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.
